103 related articles for article (PubMed ID: 8393296)
1. Effect of 1,25(OH)2D3 and its analogues on membrane phosphoinositide turnover and [Ca2+]i in Caco-2 cells.
Tien XY; Brasitus TA; Qasawa BM; Norman AW; Sitrin MD
Am J Physiol; 1993 Jul; 265(1 Pt 1):G143-8. PubMed ID: 8393296
[TBL] [Abstract][Full Text] [Related]
2. 1,25-dihydroxyvitamin D3 inhibits Na(+)-H+ exchange by stimulating membrane phosphoinositide turnover and increasing cytosolic calcium in CaCo-2 cells.
Wali RK; Baum CL; Bolt MJ; Brasitus TA; Sitrin MD
Endocrinology; 1992 Sep; 131(3):1125-33. PubMed ID: 1324151
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2 vitamin D3 activates PKC-alpha in Caco-2 cells: a mechanism to limit secosteroid-induced rise in [Ca2+]i.
Bissonnette M; Tien XY; Niedziela SM; Hartmann SC; Frawley BP; Roy HK; Sitrin MD; Perlman RL; Brasitus TA
Am J Physiol; 1994 Sep; 267(3 Pt 1):G465-75. PubMed ID: 7943245
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).
Zhou LX; Nemere I; Norman AW
J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106
[TBL] [Abstract][Full Text] [Related]
5. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
6. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
7. 1,25(OH)2 vitamin D3 stimulates membrane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium in rat colonic epithelium.
Wali RK; Baum CL; Sitrin MD; Brasitus TA
J Clin Invest; 1990 Apr; 85(4):1296-303. PubMed ID: 2156898
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.
Giuliano AR; Franceschi RT; Wood RJ
Arch Biochem Biophys; 1991 Mar; 285(2):261-9. PubMed ID: 1654769
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
Lemay J; Gascon-Barré M
Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
[TBL] [Abstract][Full Text] [Related]
12. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
14. Rapid effects of 1,25(OH)2 vitamin D3 on signal transduction systems in colonic cells.
Sitrin MD; Bissonnette M; Bolt MJ; Wali R; Khare S; Scaglione-Sewell B; Skarosi S; Brasitus TA
Steroids; 1999; 64(1-2):137-42. PubMed ID: 10323682
[TBL] [Abstract][Full Text] [Related]
15. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
Khoury R; Ridall AL; Norman AW; Farach-Carson MC
Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)2D3 blunts hormone-elevated cytosolic Ca2+ in osteoblast-like cells.
Green J; Kleeman CR; Schotland S; Ye LH
Am J Physiol; 1992 Dec; 263(6):E1070-6. PubMed ID: 1476179
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
[TBL] [Abstract][Full Text] [Related]
19. Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells.
Schroeder NJ; Burrin JM; Noonan K; Makin HL; Cunningham J
Nephron Physiol; 2003; 94(4):p62-73. PubMed ID: 12972708
[TBL] [Abstract][Full Text] [Related]
20. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
